Source Financial Advisors LLC Pfizer Inc Transaction History

Source Financial Advisors LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	SELL	$32.09 - $37.51 $2,342 - $2,738	-73 Reduced 1.12%	6,425 $213,000
Q2 2023 Jul 24, 2023	SELL	$36.12 - $41.79 $4,153 - $4,805	-115 Reduced 1.74%	6,498 $238,000
Q1 2023 Apr 20, 2023	SELL	$39.39 - $51.28 $3,348 - $4,358	-85 Reduced 1.27%	6,613 $269,000
Q4 2022 Jan 31, 2023	BUY	$41.75 - $54.5 $14,236 - $18,584	341 Added 5.36%	6,698 $343,000
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $11,727 - $14,316	-268 Reduced 4.05%	6,357 $279,000
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $4,978 - $5,903	107 Added 1.64%	6,625 $347,000
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $43,691 - $54,138	-955 Reduced 12.78%	6,518 $337,000
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $13,222 - $19,600	-320 Reduced 4.11%	7,473 $441,000
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $1,373 - $1,764	35 Added 0.45%	7,793 $335,000
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $3,878 - $4,393	-108 Reduced 1.37%	7,758 $304,000
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $18,319 - $20,660	547 Added 7.47%	7,866 $285,000
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $244,966 - $311,496	7,319 New	7,319 $269,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Source Financial Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Source Financial Advisors LLC with notifications on news.